Digital PCR and Real-Time PCR Market: Transforming Molecular Diagnostics and Research Applications

"Digital PCR and Real-Time PCR Market" in terms of revenue was estimated to be worth $8.30 billion in 2023 and is poised to reach $15.19 billion by 2031, growing at a CAGR of 7.97% from 2024 to 2031 according to a new report by InsightAce Analytic.

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1772

Market Analysis:

Digital PCR (dPCR) and real-time PCR (qPCR) are two strong molecular biology techniques for detecting and quantifying nucleic acids like DNA and RNA. The rising prevalence of genetic abnormalities is expected to boost the real-time, digital, and end-point PCR markets in future years. According to a CDC report, congenital heart abnormalities are the most prevalent birth defects, accounting for around 1% of all births in the United States. Prenatal testing can help uncover genetic differences early, which can benefit disease prevention, diagnosis, and treatment options.

Latest Drivers Restraint and Opportunities Market Snapshot:

Key factors influencing the global Digital PCR and Real-Time PCR Market are:
• Advancements in Molecular Diagnostics
• Rapidly Expanding Biotechnology and Pharmaceutical Industries
• Increasing Research Activities in Genomics and Proteomics

The following are the primary obstacles to the Digital PCR and Real-Time PCR Market's expansion:
• High Cost of Instruments and Consumables
• Complexity of Assay Development and Optimization
• Ethical and Regulatory Concerns in Genetic Testing

Future expansion opportunities for the global Digital PCR and Real-Time PCR Market include:
• Expanding Applications in Clinical Diagnostics
• Research and Drug Development
• Emerging Markets and Technological Innovations

Key Industry Insights & Findings from the Report:

• The rising need for precise and sensitive diagnostic tools for diseases such as cancer, infectious diseases, and genetic disorders is pushing the adoption of PCR technology.
• The growing interest in genomics, proteomics, and personalized medicine is expected to drive market growth.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• One of the significant concerns restraining industry growth is the initial capital investment required for purchasing dPCR and qPCR instruments.

List of Prominent Players in the Digital PCR and Real-Time PCR Market:
• Abbott Laboratories
• Becton Dickinson and Company
• Agilent Technologies, Inc.
• Analytik Jena AG
• Bio Molecular Systems
• Biomeme Inc.
• Biomérieux S.A.
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company Llc
• Danaher Corporation
• Elitech Group Sas
• Endress+Hauser
• Enzo Life Sciences, Inc.
• Eppendorf AG
• Hoffmann-LA Roche Ltd.
• Fluidigm Corporation
• JN Medsys PTE, LTD.
• Merck KGAA
• Meridian Bioscience, Inc.
• Promega Corporation
• Qiagen N.V.
• Quidel Corporation
• Quanta Biosciences Inc.
• Sacace Biotechnologies Srl
• Standard Biotools
• Stilla Technologies
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1772

Recent Developments:
• In January 2023, Allergan Aesthetics, an AbbVie subsidiary, announced the long-awaited national launch of JUVÉDERM® VOLUXTM XC. Long-lasting hyaluronic acid (HA) filler is now accessible in aesthetic offices for customers over the age of 21 who have mild to severe loss of jawline definition.
• In August 2022, Roche introduced the first digital polymerase chain reaction (PCR) device, the Digital LightCycler device. This next-generation method diagnoses disease by correctly quantifying tiny amounts of specific DNA and RNA targets that current PCR techniques cannot detect. The Digital LightCycler System allows clinical researchers to partition DNA and RNA extracted from a previously collected clinical sample into up to one hundred thousand tiny individual responses. The system may then use the PCR results to do incredibly complex data analysis.

Digital PCR and Real-Time PCR Market Dynamics:
Market Drivers: Advancements in Molecular Diagnostics
The increased desire for precise and sensitive diagnostic tools for diseases such as cancer, infectious diseases, and genetic disorders is pushing the adoption of PCR technology. Both dPCR and qPCR are important in molecular diagnostics because they can identify and quantify nucleic acids with high sensitivity and specificity. Furthermore, quick diagnosis of infectious disorders using polymerase chain reaction allows for timely intervention and the supply of suitable medicines.

Challenges: High Cost of Instruments and Consumables
The initial capital expenditure required to purchase dPCR and qPCR devices, as well as the ongoing costs of consumables such as reagents, plates, and assay kits, can be significant. Designing and optimizing PCR tests can be time-consuming and labor-intensive, necessitating a significant investment and skill in primer and probe design, reaction optimization, and data processing. The expensive cost of ownership may deter uptake, especially for smaller research institutes and facilities with restricted finances.

North America Is Expected To Grow With The Highest CAGR During The Forecast Period
The North America Digital PCR and Real-Time PCR Market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. The expanding prevalence of chronic diseases, genetic problems, infectious diseases, and increased need for rapid diagnostic tests, as well as the growing elderly population, all contribute to growth. For example, the United States Census Bureau reports that 16.9% of the population, or more than 56 million people, is 65 years or older. Furthermore, major investments in gene-based research and the existence of key players such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Agilent Technologies have had a beneficial impact on the industry.

Segmentation of Digital PCR and Real-Time PCR Market-
By Product-
• qPCR Product-& Services
o qPCR Reagents and Consumables
o qPCR Instruments
o qPCR Software and Services
• dPCR Product-& Services
o dPCR Instruments
 Droplet PCR
 Chip-based PCR
 BEAMing Digital PCR
• dPCR Reagents and Consumables
• dPCR Software and Services

By Application-
• Clinical Applications
o Infectious Disease Testing
o Oncology Testing
o Blood Screening
o Transplant Diagnostics
o Other Clinical Applications
• Research Applications
• Forensic Applications
• Environmental Applications
• Other Applications

By End-User-
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology
• CROS & CDMOS
• Forensic Laboratories
• Other End-Users

By Region-
North America-
• The US
• Canada
• Mexico

Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/1772

info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.